BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11060701)

  • 1. Anti-inflammatory drugs: a hope for Alzheimer's disease?
    Hüll M; Lieb K; Fiebich BL
    Expert Opin Investig Drugs; 2000 Apr; 9(4):671-83. PubMed ID: 11060701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
    Pasinetti GM
    J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease.
    Hoozemans JJ; Veerhuis R; Rozemuller AJ; Eikelenboom P
    Curr Drug Targets; 2003 Aug; 4(6):461-8. PubMed ID: 12866660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-steroidal anti-inflammatory drugs with selectivity for cyclooxygenase-2 in Alzheimer's disease. Rationale and perspectives].
    Blain H; Jouzeau JY; Blain A; Terlain B; Tréchot P; Touchon J; Netter P; Jeandel C
    Presse Med; 2000 Feb; 29(5):267-73. PubMed ID: 10701410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs.
    Hüll M; Lieb K; Fiebich BL
    Curr Med Chem; 2002 Jan; 9(1):83-8. PubMed ID: 11860350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease.
    Aisen PS
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S35-40. PubMed ID: 11992749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
    Blain H; Jouzeau JY; Netter P; Jeandel C
    Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
    Townsend KP; Praticò D
    FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
    Bertolini A; Ottani A; Sandrini M
    Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
    Tishler M; Langevetiz P; Nesher G
    Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.
    McGeer PL
    Drugs Aging; 2000 Jul; 17(1):1-11. PubMed ID: 10933512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
    Giovannini MG; Scali C; Prosperi C; Bellucci A; Pepeu G; Casamenti F
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):31-40. PubMed ID: 14552702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
    Halliday G; Robinson SR; Shepherd C; Kril J
    Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurones treated with cyclo-oxygenase-1 inhibitors are resistant to amyloid-beta1-42.
    Bate C; Veerhuis R; Eikelenboom P; Williams A
    Neuroreport; 2003 Nov; 14(16):2099-103. PubMed ID: 14600505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
    Aisen PS; Schafer KA; Grundman M; Pfeiffer E; Sano M; Davis KL; Farlow MR; Jin S; Thomas RG; Thal LJ;
    JAMA; 2003 Jun; 289(21):2819-26. PubMed ID: 12783912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next?
    Launer LJ
    JAMA; 2003 Jun; 289(21):2865-7. PubMed ID: 12783919
    [No Abstract]   [Full Text] [Related]  

  • 18. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia.
    Pasinetti GM
    J Alzheimers Dis; 2002 Oct; 4(5):435-45. PubMed ID: 12446975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease, inflammation and non-steroidal anti-inflammatory drugs.
    Ferencik M; Novak M; Rovensky J; Rybar I
    Bratisl Lek Listy; 2001; 102(3):123-32. PubMed ID: 11433600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.